Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
- DOI
- 10.1016/j.ejphar.2008.11.025
- Published
- 2009 Jan 14
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2008.11.025,
title = {Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.},
author = {Desbuards N and Antier D and Rochefort GY and Apfeldorfer CS and Schenck E and Hanton G and Hyvelin JM},
year = {2009},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2008.11.025},
url = {https://doi.org/10.1016/j.ejphar.2008.11.025}
}RIS
TY - JOUR TI - Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension. AU - Desbuards N AU - Antier D AU - Rochefort GY AU - Apfeldorfer CS AU - Schenck E AU - Hanton G AU - Hyvelin JM PY - 2009 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2008.11.025 UR - https://doi.org/10.1016/j.ejphar.2008.11.025 ER -
APA
N, D., D, A., GY, R., CS, A., E, S., G, H., & JM, H. (2009). Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2008.11.025
Source records
- pubmed · retrieved 2026-09-26T10:05:43.029Z
- europe-pmc · retrieved 2026-09-26T10:05:43.044Z
- hal · retrieved 2026-09-26T10:05:43.057Z